Cargando…

The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy

Cancer is a challenging problem for the global health community, and its increasing burden necessitates seeking novel and alternative therapies. Most cancers share six basic characteristics known as “cancer hallmarks”, including uncontrolled proliferation, refractoriness to proliferation blockers, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajabi, Sadegh, Maresca, Marc, Yumashev, Alexei Valerievich, Choopani, Rasool, Hajimehdipoor, Homa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066452/
https://www.ncbi.nlm.nih.gov/pubmed/33916780
http://dx.doi.org/10.3390/biom11040534
_version_ 1783682574859632640
author Rajabi, Sadegh
Maresca, Marc
Yumashev, Alexei Valerievich
Choopani, Rasool
Hajimehdipoor, Homa
author_facet Rajabi, Sadegh
Maresca, Marc
Yumashev, Alexei Valerievich
Choopani, Rasool
Hajimehdipoor, Homa
author_sort Rajabi, Sadegh
collection PubMed
description Cancer is a challenging problem for the global health community, and its increasing burden necessitates seeking novel and alternative therapies. Most cancers share six basic characteristics known as “cancer hallmarks”, including uncontrolled proliferation, refractoriness to proliferation blockers, escaping apoptosis, unlimited proliferation, enhanced angiogenesis, and metastatic spread. Apoptosis, as one of the best-known programmed cell death processes, is generally promoted through two signaling pathways, including the intrinsic and extrinsic cascades. These pathways comprise several components that their alterations can render an apoptosis-resistance phenotype to the cell. Therefore, targeting more than one molecule in apoptotic pathways can be a novel and efficient approach for both identifying new anticancer therapeutics and preventing resistance to therapy. The main purpose of this review is to summarize data showing that various plant extracts and plant-derived molecules can activate both intrinsic and extrinsic apoptosis pathways in human cancer cells, making them attractive candidates in cancer treatment.
format Online
Article
Text
id pubmed-8066452
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80664522021-04-25 The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy Rajabi, Sadegh Maresca, Marc Yumashev, Alexei Valerievich Choopani, Rasool Hajimehdipoor, Homa Biomolecules Review Cancer is a challenging problem for the global health community, and its increasing burden necessitates seeking novel and alternative therapies. Most cancers share six basic characteristics known as “cancer hallmarks”, including uncontrolled proliferation, refractoriness to proliferation blockers, escaping apoptosis, unlimited proliferation, enhanced angiogenesis, and metastatic spread. Apoptosis, as one of the best-known programmed cell death processes, is generally promoted through two signaling pathways, including the intrinsic and extrinsic cascades. These pathways comprise several components that their alterations can render an apoptosis-resistance phenotype to the cell. Therefore, targeting more than one molecule in apoptotic pathways can be a novel and efficient approach for both identifying new anticancer therapeutics and preventing resistance to therapy. The main purpose of this review is to summarize data showing that various plant extracts and plant-derived molecules can activate both intrinsic and extrinsic apoptosis pathways in human cancer cells, making them attractive candidates in cancer treatment. MDPI 2021-04-03 /pmc/articles/PMC8066452/ /pubmed/33916780 http://dx.doi.org/10.3390/biom11040534 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Rajabi, Sadegh
Maresca, Marc
Yumashev, Alexei Valerievich
Choopani, Rasool
Hajimehdipoor, Homa
The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
title The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
title_full The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
title_fullStr The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
title_full_unstemmed The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
title_short The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
title_sort most competent plant-derived natural products for targeting apoptosis in cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8066452/
https://www.ncbi.nlm.nih.gov/pubmed/33916780
http://dx.doi.org/10.3390/biom11040534
work_keys_str_mv AT rajabisadegh themostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT marescamarc themostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT yumashevalexeivalerievich themostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT choopanirasool themostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT hajimehdipoorhoma themostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT rajabisadegh mostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT marescamarc mostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT yumashevalexeivalerievich mostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT choopanirasool mostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy
AT hajimehdipoorhoma mostcompetentplantderivednaturalproductsfortargetingapoptosisincancertherapy